YaHooka Forums - View Single Post - Nazi Con Flicts of Interest Bush Barthwell & Drugs

DdC · 04-26-2006, 07:24 PM

FDA learns from DEA agent; shoots self in foot
Boy, I wonder if anyone at the FDA foresaw this. The FDA statement against medical marijuana has been received around the nation (and even the world), as if NASA had proclaimed that the earth is flat.

Souder Orders to FDA Backfiring!
F.D.A. Misses Medical Benefit From Marijuana

Editorial: FDA Issues Report for Political Purposes*
Source: Daily Collegian April 26, 2006
Pennsylvania -- The Food and Drug Administration said Thursday that scientific research fails to support the medical use of marijuana. Forgive the skepticism, but why now, seven years after the National Academy of Sciences found marijuana rather, "well suited for particular conditions," should Americans question the legitimate uses of the drug?
Read More... cannabisnews.com/news/thread21780

UK: US Interest in MS Drug Boosts GW By Stephen Fole
Published: April 25, 2006 New York
US investors piled into GW Pharmaceuticals yesterday amid excitement over the prospects for an American launch of its revolutionary cannabis-based treatment for multiple sclerosis. Health regulators have sent an uncompromising message that smoked cannabis will not be approved for use by MS sufferers, leaving the way open for GW's under-the-tongue spray version of the drug. Justin Gover, the managing director, said GW'sshares had attracted attention from private investors.

Cannabis, cannabin of 1907
Cannabis extract made by Parke, Davis & Co. circa 1910
CANNABIS INDICA. U. S., Br., INDIAN CANNABIS [Indian Hemp]
" The dried flowering tops of the pistillate plants of Cannabis sativa Linne (Fain. Moracece), grown in the East Indies and gathered while the fruits are yet undeveloped, and carrying the whole of their natural resin." U. S. " The dried flowering or fruiting tops of the female plant of Cannabis sativa, Linn., grown in India; from which the resin has not been removed."

Cannabis extract made by Parke, Davis & Co. circa 1910

Former Deputy Drug Czar Andrea Barthwell is the new spokesperson for getting GW Pharmaceuticals' Sativex approved for use in the United States

21 May 2003 - Bayer and GW Pharmaceuticals
announce marketing agreement on pioneering new cannabis-based treatment

Adolf von Baeyer – Biography

Opium: An 1897 Bayer Heroin Ad

Heroin and Aspirin were both sold by Adolph Von Bayer and his company. Above link is a U.S. ad from 1897 it includes information about both Bayer Aspirin and Bayer Heroin. Aspirin and heroin were both legal at the time and heroin was marketed as a cough suppressant.

Bayer
German chemical and pharmaceutical company founded in the 19th century. Between the mid-1920s and mid-1940s Bayer was part of the notorious IG Farben along with BASF and Hoechst. IG Farben developed chemical weapons and used slave labour. At the end of WW2 several IG Farben executives were jailed for war crimes.

Bayer had considerable agro-chemical interests but no direct involvement in GM crops before its purchase of Aventis CropScience, from Aventis and Schering in 2002, to form Bayer CropScience. Bayer is the only large company to hang on to something approaching the life science concept, keeping agriculture, chemicals, polymers and pharmaceuticals within one company.

THE RISE OF THE FOURTH REICH

THE BUSH FAMILY OLIGARCHY
Funding the Hitler Project

"Bush - Nazi Link Confirmed" by John Buchanan
New Hampshire Gazette, Oct. 10, 2003

In 1933, shortly after Hitler's appointment as Chancellor of Germany, the German Parliament was set on fire by the Nazis and the Communists were blamed for this act of terrorism against the German people. Following the Nazi-inspired arson, Hitler exploited the outrage of the German citizens to arrogate to himself dictatorial powers, which he promised would be used to rid Germany of Communists.

More recently, the U.S. government's response to a frightened and enraged U.S. citizenry over the September 11 attacks on the Pentagon and World Trade Center has been eerily reminiscent of Hitler's strategy' that is geared to exacerbate the reaction of fear and hostility and to put on a fast track three initiatives which bear an uneasy resemblance to the Nazi takeover of Germany

Carlyle covers up by Naomi Klein The Nation
Revelations that the Carlyle Group was involved in a secret deal to profit from Iraq's debt have vanished under a spell of silence. James Baker: in the face of overwhelming evidence of a glaring conflict of interest between Baker's stake in Carlyle and his post as Bush's special envoy on Iraq's debt, Carlyle simply denied everything

Bushladen and the Terrorists Carlyles Groups

GOPerverted Officials

One-third of drug safety advisers in U.S. show conflicts of interest
Of the nearly 3,000 panellists appointed based on their drug expertise, 28 per cent disclosed a financial relationship with the company making the drug under review or a competitor, the consumer group reports in Wednesday's issue of the Journal of the American Medical Association.

The FDA is not required to follow the recommendations made by outside experts on approving a new drug, although it usually does. The review of common conflicts of interest found:

* 19 per cent of consulting involved over $10,000.
* 23 per cent of contracts or grants exceeded $100,000.
* 30 per cent of investments were over $25,000

The FDA turns to outside experts for advising on approving new drugs''

America's Model for Corruption in Law and Government

Drug War Kills More Than a Cop a Month
Ecstasy Research Wins Final FDA Approval
Scotland Yard Chief Anthony Wills Says, "Legalize It"
Nobel Winner Garcia Márquez Says, "Legalize Drugs"
Doctors, Scientists Urge Media to End "Crack Baby" Myth
Judge Kane Speaks Out Again, Lambastes Federal Drug War

Law Enforcement Against Prohibition

Bayer 101

A history of deception

Andrea Barthwell is a former Deputy Director of the Office of National Drug Control Policy, where her job was to oppose medical marijuana, regardless of the facts. The function of the ONDCP as charged by Congress was one of propaganda. In fact, the GAO said as much (pdf) in a reply to Representative Ron Paul who was complaining about incorrect information being disseminated by another Deputy Director:

"... while the Deputy Director's statements pertaining to marijuana may be disputed by some with different viewpoints, they were made within the context of ONDCP's statutory responsibilities, which include taking such actions as necessary to oppose efforts to legalize certain controlled substances such as marijuana. ...

Given this role, we do not see a need to examine the accuracy of the Deputy Director's individual statements in detail."

04-26-2006, 07:24 PM	#1 (permalink)
DdC Decade Yahookan Join Date: Feb 1999 Location: Santa Cruz,CA,USA Posts: 2,088 Blog Entries: 5 Thanks: 47 Thanked 570 Times in 378 Posts	Nazi Con Flicts of Interest Bush Barthwell & Drugs FDA learns from DEA agent; shoots self in foot Boy, I wonder if anyone at the FDA foresaw this. The FDA statement against medical marijuana has been received around the nation (and even the world), as if NASA had proclaimed that the earth is flat. Souder Orders to FDA Backfiring! F.D.A. Misses Medical Benefit From Marijuana Editorial: FDA Issues Report for Political Purposes* Source: Daily Collegian April 26, 2006 Pennsylvania -- The Food and Drug Administration said Thursday that scientific research fails to support the medical use of marijuana. Forgive the skepticism, but why now, seven years after the National Academy of Sciences found marijuana rather, "well suited for particular conditions," should Americans question the legitimate uses of the drug? Read More... cannabisnews.com/news/thread21780 UK: US Interest in MS Drug Boosts GW By Stephen Fole Published: April 25, 2006 New York US investors piled into GW Pharmaceuticals yesterday amid excitement over the prospects for an American launch of its revolutionary cannabis-based treatment for multiple sclerosis. Health regulators have sent an uncompromising message that smoked cannabis will not be approved for use by MS sufferers, leaving the way open for GW's under-the-tongue spray version of the drug. Justin Gover, the managing director, said GW'sshares had attracted attention from private investors. Cannabis, cannabin of 1907 Cannabis extract made by Parke, Davis & Co. circa 1910 CANNABIS INDICA. U. S., Br., INDIAN CANNABIS [Indian Hemp] " The dried flowering tops of the pistillate plants of Cannabis sativa Linne (Fain. Moracece), grown in the East Indies and gathered while the fruits are yet undeveloped, and carrying the whole of their natural resin." U. S. " The dried flowering or fruiting tops of the female plant of Cannabis sativa, Linn., grown in India; from which the resin has not been removed." Cannabis extract made by Parke, Davis & Co. circa 1910 Former Deputy Drug Czar Andrea Barthwell is the new spokesperson for getting GW Pharmaceuticals' Sativex approved for use in the United States 21 May 2003 - Bayer and GW Pharmaceuticals announce marketing agreement on pioneering new cannabis-based treatment Adolf von Baeyer – Biography Opium: An 1897 Bayer Heroin Ad Heroin and Aspirin were both sold by Adolph Von Bayer and his company. Above link is a U.S. ad from 1897 it includes information about both Bayer Aspirin and Bayer Heroin. Aspirin and heroin were both legal at the time and heroin was marketed as a cough suppressant. Bayer German chemical and pharmaceutical company founded in the 19th century. Between the mid-1920s and mid-1940s Bayer was part of the notorious IG Farben along with BASF and Hoechst. IG Farben developed chemical weapons and used slave labour. At the end of WW2 several IG Farben executives were jailed for war crimes. Bayer had considerable agro-chemical interests but no direct involvement in GM crops before its purchase of Aventis CropScience, from Aventis and Schering in 2002, to form Bayer CropScience. Bayer is the only large company to hang on to something approaching the life science concept, keeping agriculture, chemicals, polymers and pharmaceuticals within one company. THE RISE OF THE FOURTH REICH THE BUSH FAMILY OLIGARCHY Funding the Hitler Project "Bush - Nazi Link Confirmed" by John Buchanan New Hampshire Gazette, Oct. 10, 2003 In 1933, shortly after Hitler's appointment as Chancellor of Germany, the German Parliament was set on fire by the Nazis and the Communists were blamed for this act of terrorism against the German people. Following the Nazi-inspired arson, Hitler exploited the outrage of the German citizens to arrogate to himself dictatorial powers, which he promised would be used to rid Germany of Communists. More recently, the U.S. government's response to a frightened and enraged U.S. citizenry over the September 11 attacks on the Pentagon and World Trade Center has been eerily reminiscent of Hitler's strategy' that is geared to exacerbate the reaction of fear and hostility and to put on a fast track three initiatives which bear an uneasy resemblance to the Nazi takeover of Germany Carlyle covers up by Naomi Klein The Nation Revelations that the Carlyle Group was involved in a secret deal to profit from Iraq's debt have vanished under a spell of silence. James Baker: in the face of overwhelming evidence of a glaring conflict of interest between Baker's stake in Carlyle and his post as Bush's special envoy on Iraq's debt, Carlyle simply denied everything Bushladen and the Terrorists Carlyles Groups GOPerverted Officials One-third of drug safety advisers in U.S. show conflicts of interest Of the nearly 3,000 panellists appointed based on their drug expertise, 28 per cent disclosed a financial relationship with the company making the drug under review or a competitor, the consumer group reports in Wednesday's issue of the Journal of the American Medical Association. The FDA is not required to follow the recommendations made by outside experts on approving a new drug, although it usually does. The review of common conflicts of interest found: * 19 per cent of consulting involved over $10,000. * 23 per cent of contracts or grants exceeded $100,000. * 30 per cent of investments were over $25,000 The FDA turns to outside experts for advising on approving new drugs'' America's Model for Corruption in Law and Government Drug War Kills More Than a Cop a Month Ecstasy Research Wins Final FDA Approval Scotland Yard Chief Anthony Wills Says, "Legalize It" Nobel Winner Garcia Márquez Says, "Legalize Drugs" Doctors, Scientists Urge Media to End "Crack Baby" Myth Judge Kane Speaks Out Again, Lambastes Federal Drug War Law Enforcement Against Prohibition Bayer 101 A history of deception Andrea Barthwell is a former Deputy Director of the Office of National Drug Control Policy, where her job was to oppose medical marijuana, regardless of the facts. The function of the ONDCP as charged by Congress was one of propaganda. In fact, the GAO said as much (pdf) in a reply to Representative Ron Paul who was complaining about incorrect information being disseminated by another Deputy Director: "... while the Deputy Director's statements pertaining to marijuana may be disputed by some with different viewpoints, they were made within the context of ONDCP's statutory responsibilities, which include taking such actions as necessary to oppose efforts to legalize certain controlled substances such as marijuana. ... Given this role, we do not see a need to examine the accuracy of the Deputy Director's individual statements in detail."